These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 16622558)

  • 1. [Olfactory groove meningioma: correlation between clinicoradiological features and proliferative index (Mib-1)].
    Paiva Neto MA; Tella OI; Herculano MA; Stávale JN; Bonatteli AP
    Arq Neuropsiquiatr; 2006 Mar; 64(1):77-82. PubMed ID: 16622558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Meningioma: proliferating potential and clinicoradiological features.
    Nakasu S; Nakajima M; Matsumura K; Nakasu Y; Handa J
    Neurosurgery; 1995 Dec; 37(6):1049-55. PubMed ID: 8584144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MIB-1 staining index and peritumoral brain edema of meningiomas.
    Ide M; Jimbo M; Yamamoto M; Umebara Y; Hagiwara S; Kubo O
    Cancer; 1996 Jul; 78(1):133-43. PubMed ID: 8646709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and histopathological analysis of proliferative potentials of recurrent and non-recurrent meningiomas.
    Matsuno A; Fujimaki T; Sasaki T; Nagashima T; Ide T; Asai A; Matsuura R; Utsunomiya H; Kirino T
    Acta Neuropathol; 1996; 91(5):504-10. PubMed ID: 8740231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicting the probability of meningioma recurrence based on the quantity of peritumoral brain edema on computerized tomography scanning.
    Mantle RE; Lach B; Delgado MR; Baeesa S; Bélanger G
    J Neurosurg; 1999 Sep; 91(3):375-83. PubMed ID: 10470810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recurrence of olfactory groove meningiomas.
    Obeid F; Al-Mefty O
    Neurosurgery; 2003 Sep; 53(3):534-42; discussion 542-3. PubMed ID: 12943570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation between histological grade, MIB-1, p53, and recurrence in 69 completely resected primary intracranial meningiomas with a 6 year mean follow-up.
    Lanzafame S; Torrisi A; Barbagallo G; Emmanuele C; Alberio N; Albanese V
    Pathol Res Pract; 2000; 196(7):483-8. PubMed ID: 10926326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Value of KI-67/MIB-1 labeling index and simpson grading system to predict the recurrence of who grade I intracranial meningiomas compared to who grade II.
    Prat-Acín R; Guarín-Corredor MJ; Galeano-Senabre I; Ayuso-Sacido A; Vera-Sempere F
    J Clin Neurosci; 2021 Apr; 86():32-37. PubMed ID: 33775343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postoperative residual tumor growth of meningioma can be predicted by MIB-1 immunohistochemistry.
    Nakaguchi H; Fujimaki T; Matsuno A; Matsuura R; Asai A; Suzuki I; Sasaki T; Kirino T
    Cancer; 1999 May; 85(10):2249-54. PubMed ID: 10326705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Analysis of the proliferative potential of meningiomas with MIB-1 monoclonal antibodies].
    Miyagami M; Shibuya T; Miyagi A; Tsubokawa T
    No To Shinkei; 1996 Jan; 48(1):39-43. PubMed ID: 8679317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical detection of progesterone receptors and the correlation with Ki-67 labeling indices in paraffin-embedded sections of meningiomas.
    Nagashima G; Aoyagi M; Wakimoto H; Tamaki M; Ohno K; Hirakawa K
    Neurosurgery; 1995 Sep; 37(3):478-82; discussion 483. PubMed ID: 7501113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Absence of histological signs of tumor progression in recurrences of completely resected meningiomas.
    Schiffer D; Ghimenti C; Fiano V
    J Neurooncol; 2005 Jun; 73(2):125-30. PubMed ID: 15981101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Ki-67 proliferation antigen in meningiomas. Experience in 600 cases.
    Roser F; Samii M; Ostertag H; Bellinzona M
    Acta Neurochir (Wien); 2004 Jan; 146(1):37-44; discussion 44. PubMed ID: 14740263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of Ki-67/MIB-1 proliferation index in meningiomas.
    Torp SH; Lindboe CF; Grønberg BH; Lydersen S; Sundstrøm S
    Clin Neuropathol; 2005; 24(4):170-4. PubMed ID: 16033133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pericytosis and edema generation: a unique clinicopathological variant of meningioma.
    Robinson JC; Challa VR; Jones DS; Kelly DL
    Neurosurgery; 1996 Oct; 39(4):700-6; discussion 706-7. PubMed ID: 8880761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The significance of nucleolar organizer region (AgNOR) score in predicting meningioma recurrence.
    Kunishio K; Ohmoto T; Matsuhisa T; Maeshiro T; Furuta T; Matsumoto K
    Cancer; 1994 Apr; 73(8):2200-5. PubMed ID: 8156526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histopathologic features and MIB-1 labeling indices in recurrent and nonrecurrent meningiomas.
    Abramovich CM; Prayson RA
    Arch Pathol Lab Med; 1999 Sep; 123(9):793-800. PubMed ID: 10458826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MIB-1 labeling indices in benign, aggressive, and malignant meningiomas: a study of 90 tumors.
    Abramovich CM; Prayson RA
    Hum Pathol; 1998 Dec; 29(12):1420-7. PubMed ID: 9865827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The significance of Ki-67/MIB-1 labeling index in human meningiomas: a literature study.
    Abry E; Thomassen IØ; Salvesen ØO; Torp SH
    Pathol Res Pract; 2010 Dec; 206(12):810-5. PubMed ID: 20951502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of factors affecting the long-term functional outcome of patients with skull base meningioma.
    Nakao N; Ohkawa T; Miki J; Nishibayahsi H; Ogura M; Uematsu Y; Itakura T
    J Clin Neurosci; 2011 Jul; 18(7):895-8. PubMed ID: 21565513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.